Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.

Transforming growth factor beta (TGF-beta) is a family of proteins which act as a potent growth inhibitor for most cell types including epithelial cells. TGF-beta is synthesized as latent high molecular weight complexes, composed of TGF-beta, the NH2-terminal part of the TGF-beta precursor and the third molecule, the latent TGF-beta binding protein (LTBP). We here ascertain that TGF-beta is expressed in human prostatic cancer tissue as well as in cystectomized prostatic tissue and in materials from transurethral resections with benign prostatic hyperplasia, analyzed by immunohistochemistry. TGF-beta is observed in both epithelial cells and stromal cells. No significant correlation was obtained between TGF-beta expression in tumor cells and their degree of differentiation. However, analysis by immunohistochemistry using antibodies against LTBP revealed that specimens from histopathologically verified human prostatic cancer are mostly negative for this molecule, although it is expressed in cystectomized prostatic and benign prostatic hyperplasia tissues. These results indicate that in cystectomized prostatic and benign prostatic hyperplasia tissues, TGF-beta may be produced in a complex associated with LTBP; whereas in prostatic carcinoma, TGF-beta is produced without associating with LTBP. The biological significance of the production of TGF-beta in relation to LTBP and the possible association with prognosis are discussed.

[1]  K. Miyazono,et al.  Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. , 1992, The Journal of biological chemistry.

[2]  R. Glanville,et al.  Partial sequence of a candidate gene for the Marfan syndrome , 1991, Nature.

[3]  L. Bonewald,et al.  Latent Forms of Transforming Growth Factor-β (TGFβ) Derived from Bone Cultures: Identification of a Naturally Occurring 100-kDa Complex with Similarity to Recombinant Latent TGFβ , 1991 .

[4]  K. Miyazono,et al.  Latent forms of TGF-beta: molecular structure and mechanisms of activation. , 1991, Ciba Foundation symposium.

[5]  K. Miyazono,et al.  TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences , 1990, Cell.

[6]  H. Moses,et al.  Transforming growth factors and the regulation of cell proliferation. , 1990, European journal of biochemistry.

[7]  K. Miyazono,et al.  High-yield purification of platelet-derived endothelial cell growth factor: structural characterization and establishment of a specific antiserum. , 1989, Biochemistry.

[8]  M. Sporn,et al.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice , 1989, The Journal of cell biology.

[9]  U. Hellman,et al.  A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. , 1988, The Journal of biological chemistry.

[10]  A. Schuurmans,et al.  Androgens and transforming growth factor β modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP) , 1988, Molecular and Cellular Endocrinology.

[11]  N. Kyprianou,et al.  Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. , 1988, Endocrinology.

[12]  P. ten Dijke,et al.  Identification of another member of the transforming growth factor type beta gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.

[14]  M. Sporn,et al.  Antibodies to peptide determinants in transforming growth factor beta and their applications. , 1988, Biochemistry.

[15]  H. Marquardt,et al.  Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. , 1987, Biochemistry.

[16]  E. Wilson,et al.  Growth factors in the prostate. , 1987, Progress in clinical and biological research.

[17]  F. Mostofi,et al.  Grading of prostatic carcinoma. , 1975, Cancer chemotherapy reports.